Myriad CLO has 4,398 shares withheld for taxes

Myriad Genetics’ Chief Legal Officer had shares withheld to cover taxes on vesting equity, leaving her with over 300,000 MYGN shares directly owned.

Rhea-AI Filing Summary

MYRIAD GENETICS INC (MYGN) reported a Form 4 for Chief Legal Officer Jennifer Lynne Fox showing that on September 3, 2026, 4,398 shares of Common Stock were withheld by the company to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units. These withheld shares were treated as a disposition for reporting purposes at $3.23 per share, based on the closing price on that date, and were not an open-market sale. After this tax-withholding event, Fox directly held 305,964 shares of MYGN Common Stock. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Tax Withholding: 4,398 shares

Tax Withholding 1 txn

Insider Fox Jennifer Lynne

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	4,398	$3.23	$14K

Holdings After Transaction: Common Stock — 305,964 shares (Direct)

Footnotes (1)

1. F1. Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 3, 2026.

Key Figures

Shares withheld for taxes: 4,398 shares Per-share value for withholding: $3.23 per share Post-transaction holdings: 305,964 shares

3 metrics

Shares withheld for taxes 4,398 shares Common Stock withheld on September 3, 2026 to satisfy tax withholding obligations on RSU vesting

Per-share value for withholding $3.23 per share Closing price of MYGN Common Stock on September 3, 2026 used to determine shares withheld

Post-transaction holdings 305,964 shares Common Stock directly owned by Jennifer Lynne Fox after the September 3, 2026 transaction

Key Terms

restricted stock units, tax withholding obligations, closing price

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units previously granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations in connection"

closing price financial

"determined based on the closing price of Issuer's Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MYGN report for Jennifer Lynne Fox on September 3, 2026?

MYGN reported that Chief Legal Officer Jennifer Lynne Fox had 4,398 shares of Common Stock withheld by the company on September 3, 2026 to satisfy tax withholding obligations from the vesting of restricted stock units.

Was the September 3, 2026 MYGN Form 4 transaction an open-market sale?

No. The filing states the 4,398 shares were withheld by the issuer to cover tax withholding obligations on RSU vesting, and not sold in the open market. It is reported as a tax-related disposition rather than a discretionary share sale.

At what price were the MYGN shares valued for the tax withholding on September 3, 2026?

The withheld 4,398 MYGN shares were valued at $3.23 per share, which the filing states was the closing price of Myriad Genetics’ Common Stock on September 3, 2026 used to determine the number of shares withheld.

How many MYGN shares does Jennifer Lynne Fox hold after the reported transaction?

Following the tax-withholding transaction, Chief Legal Officer Jennifer Lynne Fox directly holds 305,964 shares of Myriad Genetics Common Stock, as reported in the Form 4’s post-transaction ownership line.

Was the MYGN Form 4 transaction by Jennifer Lynne Fox under a Rule 10b5-1 plan?

No. The Form 4 indicates no Rule 10b5-1 trading plan for this transaction. The shares were withheld by the issuer solely to satisfy tax withholding obligations from vesting restricted stock units.

What role does the insider in this MYGN Form 4 hold at the company?

The reporting person in this MYGN Form 4, Jennifer Lynne Fox, is identified as the company’s Chief Legal Officer, and the reported transaction relates to equity compensation in the form of restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:19 PM Accepted by SEC EDGAR 09/08/2026 - 04:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fox Jennifer Lynne

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/03/2026		F		4,398(1)	D	$3.23	305,964	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 3, 2026.

Remarks:

	By: Justin Hunter For: Jennifer Lynne Fox	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)